Using advanced imaging to detect bleeding cysts in kidney disease
QSM for detection of hemorrhaging cysts and risk stratification in ADPKD
This study is testing a new imaging method to help doctors find and understand bleeding cysts in people with autosomal dominant polycystic kidney disease (ADPKD), so they can better predict how these cysts might affect kidney health and treatment outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11050780 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technique called renal quantitative susceptibility mapping (QSM) to accurately identify and measure hemorrhagic cysts in patients with autosomal dominant polycystic kidney disease (ADPKD). By detecting these cysts, the research aims to provide better risk stratification for patients, helping to predict the decline in kidney function. The study will analyze how these cysts relate to kidney health and the effectiveness of existing treatments. Patients will be monitored to assess the impact of hemorrhagic cysts on their overall kidney function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autosomal dominant polycystic kidney disease (ADPKD), particularly those with a history of hemorrhagic cysts.
Not a fit: Patients without a diagnosis of ADPKD or those who do not have hemorrhagic cysts may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for identifying patients at risk of rapid kidney function decline, allowing for more personalized treatment plans.
How similar studies have performed: Previous research has shown that imaging techniques can effectively identify cysts and their impact on kidney disease progression, suggesting that this approach may yield valuable insights.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Dimov, Alexey — Weill Medical Coll of Cornell Univ
- Study coordinator: Dimov, Alexey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.